Sign in
Create a Profile
Cannabinoid Receptor Function & Alcoholism
Diseases and Conditions Researched
Alcoholism
What is the purpose of this trial?
This study attempts to characterize the effects of tetrahydrocannabinol (THC). Tetrahydrocannabinol is the active ingredient of marijuana, cannabis, "ganja", or "pot". This study will involve healthy volunteers who 1) have no history of alcoholism in their family or 2) have a family history of alcoholism. This study looks at individuals with or without a family history of alcoholism to determine if there is a difference between the two groups in the response to THC.
Participation Guidelines
Gender: Both
This trial accepts healthy volunteers.
Click here for detailed participation information for this trial.
| Sponsors: | National Institute on Alcohol Abuse and Alcoholism (NIAAA); Yale University |
|---|---|
| Dates: | February 18, 2008 |
| Last Updated: | April 25, 2012 |
| Study HIC#: | 0707002888 |
| Clinicaltrials.gov ID: | NCT00624715 |
How will my information be used?
For more information about this trial, contact:
Ashley Schnakenberg
203-932-5711 ext 4485
ashley.schnakenberg@yale.edu
Principal Investigator
D'Souza, Deepak C.
Psychiatry
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.
